The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Amgen; AstraZeneca; Celgene; Eisai; Genomic Health; GlaxoSmithKline; Hexal; Janssen-Cilag; Medac; Novartis; Pierre Fabre; Roche/Genentech
Consulting or Advisory Role - Amgen; Celgene; Eisai; Genomic Health; Janssen-Cilag; Pierre Fabre
Quality of patient-reported outcome for long-term survival of early breast cancer trials.
 
Gunter Von Minckwitz
Research Funding - Amgen (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Celgene (Inst); GlaxoSmithKline (Inst); Myriad Genetics (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Sanofi (Inst); Teva (Inst)
 
Jan Steffen
No Relationships to Disclose
 
Serban Dan Costa
No Relationships to Disclose
 
Wolfgang Janni
No Relationships to Disclose
 
Marc Thill
No Relationships to Disclose
 
Volkmar Müller
No Relationships to Disclose
 
Tanja Neunhoeffer
No Relationships to Disclose
 
Hans Georg Lenhard
No Relationships to Disclose
 
Gabriele Feisel
No Relationships to Disclose
 
Iris Schrader
No Relationships to Disclose
 
Uwe E. Kullmer
No Relationships to Disclose
 
Michael Wittenberg
No Relationships to Disclose
 
Valentina Nekljudova
No Relationships to Disclose
 
Sibylle Loibl
No Relationships to Disclose